CCM Investment Advisers LLC Reduces Stock Holdings in Vertex ...

3 days ago · CCM Investment Advisers LLC lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 25.9% in the 4th quarter, …

9%
OFF

CCM Investment Advisers LLC Reduces Stock Holdings In Vertex ...

2 weeks from now

3 days ago · CCM Investment Advisers LLC lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 25.9% in the 4th quarter, …

marketbeat.com

9%
OFF

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares …

2 weeks from now

Aug 9, 2024 · CCM Investment Advisers LLC lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.9% in the second quarter, according to the …

mayfieldrecorder.com

84%
OFF

Ccm Investment Advisers 13F Filings And Top Holdings And Stakes

2 weeks from now

Ccm Investment Advisers was a net buyer of stock by $41M. Ccm Investment Advisers has $852M in assets under management (AUM), dropping by 1.84%. Central Index Key (CIK): ...

stockzoa.com

$1093282659
OFF

CCM INVESTMENT ADVISERS LLC Top 13F Holdings

2 weeks from now

CCM Investment Advisers is based out of Columbia. CCM Investment Advisers is a large advisory firm with 905 clients and discretionary assets under management (AUM) of $1,093,282,659 …

whalewisdom.com

1%
OFF

CCM Investment Advisers LLC Reduces Position In Netflix

2 weeks from now

3 days ago · CCM Investment Advisers LLC reduced its stake in Netflix, Inc. (NASDAQ:NFLX - Free Report) by 6.1% during the fourth quarter, according to the company in its most recent …

marketbeat.com

$897
OFF

$897Million CCM INVESTMENT ADVISERS LLC Q3 2024 13F …

2 weeks from now

Oct 9, 2024 · CCM INVESTMENT ADVISERS LLC reported 77 stock holdings with total value $897M as of Q3 2024. Top holdings included NVDA, AAPL, MSFT, AMZN, and META. Open …

portfoliosavvy.com

$836
OFF

CCM INVESTMENT ADVISERS LLC - Hedge Fund 13F Holdings

2 weeks from now

CCM INVESTMENT ADVISERS LLC is a hedge fund with $836.2 Millions invested in stocks. Its top stocks are NVDA, MSFT, AMZN as per latest 13F stock holdings. Stock Ideas. New. …

grufity.com

4%
OFF

B. Riley Wealth Advisors Inc. Reduces Position In Vertex ...

2 weeks from now

Dec 15, 2024 · B. Riley Wealth Advisors Inc. cut its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 13.4% in the 3rd quarter, according to the …

marketbeat.com

1%
OFF

CCM Investment Advisers LLC Reduces Holdings In Fiserv

2 weeks from now

3 days ago · CCM Investment Advisers LLC lowered its stake in shares of Fiserv, Inc. (NYSE:FI - Free Report) by 10.1% during the 4th quarter, according to the company in its most recent …

marketbeat.com

2%
OFF

JPMorgan Chase & Co. Lowers Stock Holdings In Vertex, Inc

2 weeks from now

Jan 4, 2025 · Quest Partners LLC bought a new position in Vertex in the 2nd quarter worth approximately $37,000. Advisors Asset Management Inc. grew its stake in Vertex by 126.2% …

marketbeat.com

3%
OFF

Anchor Investment Management LLC Increases Stock Position In …

2 weeks from now

Dec 13, 2024 · Anchor Investment Management LLC increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1,352.3% in the third …

marketbeat.com

FAQs about CCM Investment Advisers LLC Reduces Stock Holdings in Vertex ... Coupon?

Who owns Vertex Pharmaceuticals?

Top institutional shareholders of Vertex Pharmaceuticals include State Street Corp (4.59%), FMR LLC (4.09%), Geode Capital Management LLC (2.30%) and Jennison Associates LLC (2.16%). ...

Are Vertex Pharmaceuticals insiders buying or selling more stock?

In the past three months, Vertex Pharmaceuticals insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,178.00 in company stock. Only 0.20% of the stock of Vertex Pharmaceuticals is held by insiders. ...

Does Vertex Pharmaceuticals pay a dividend?

Vertex Pharmaceuticals does not currently pay a dividend. Vertex Pharmaceuticals does not have a long track record of dividend growth. Vertex Pharmaceuticals has a news sentiment score of 0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). ...

How has Vertex Pharmaceuticals performed in recent years?

Vertex Pharmaceuticals has achieved significant financial growth in recent years, reflecting its successful drug development efforts. Impressive revenue metrics and robust earnings metrics indicate the company's ability to translate its research into profitable treatments efficiently. ...

How did Vertex Pharmaceuticals (VRTX) perform in a quarter?

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced its quarterly earnings data on Monday, November, 4th. The pharmaceutical company reported $4.38 EPS for the quarter, beating analysts' consensus estimates of $3.61 by $0.77. Vertex Pharmaceuticals's revenue for the quarter was up 11.6% compared to the same quarter last year. ...

What does vertex do?

The company specializes in researching, developing, and commercializing innovative therapies for various medical conditions, primarily focusing on cystic fibrosis. Using cutting-edge science and technology, Vertex has become a leading player in the biotech industry, particularly in the field of precision medicine. ...